Nemaura Medical is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT, and proBEAT. sugarBEAT, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real-time glucose measurements and daily glucose trend data, that helps people with diabetes and pre-diabetes to better manage, reverse and prevent the onset of diabetes. Nemaura Medical was founded in 2009 and is based in New York, New York.
